Xylazine Increasingly ID'd in Illicitly Manufactured Fentanyl Overdose Deaths
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, July 6, 2023 -- From 2019 to 2022, there was a considerable increase in illicitly manufactured fentanyl (IMF)-involved overdose deaths with xylazine detected, according to research published in the June 30 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Mbabazi Kariisa, Ph.D., from the CDC in Atlanta, and colleagues described IMF-involved overdose deaths with and without xylazine that occurred during January 2019 to June 2022 using data from the CDC State Unintentional Drug Overdose Reporting System.
The researchers found a 276 percent increase, from 2.9 to 10.9 percent, in the monthly percentage of IMF-involved deaths with xylazine detected among 21 jurisdictions, including 20 states and the District of Columbia. Among IMF-involved deaths during January 2021 to June 2022 in 32 jurisdictions, xylazine was detected in more jurisdictions in the Northern U.S. Census Bureau region; across jurisdictions, there was variation in listing detected xylazine as a cause of death.
"Routine toxicology testing for xylazine in suspected overdose cases is critical for accurate surveillance, and further investigation of xylazine's potency and effects on humans is needed to clarify morbidity and overdose risks and to guide prevention and response efforts," the authors write. "Insight into motivations for adding xylazine to IMF products, and whether persons actively seek xylazine, could help anticipate future drug supply changes and tailor prevention and response efforts."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Small Number of Procedures Account for Large Number of Opioid Prescriptions
FRIDAY, June 28, 2024 -- A small number of surgical procedures, including orthopedic procedures and cesarean delivery, account for a large proportion of opioid prescriptions...
Only One-Quarter of Adults Who Needed Opioid Use Disorder Meds in 2022 Received Them
THURSDAY, June 27, 2024 -- Only one-quarter of adults who needed opioid use disorder (OUD) treatment in 2022 received medications for OUD, according to research published in the...
ADA: Bisphenol A Linked to Reduced Peripheral Insulin Sensitivity
THURSDAY, June 27, 2024 -- Bisphenol A (BPA) administration is associated with reduced peripheral insulin sensitivity among healthy adults, according to a study presented at the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.